|
|
European Centre for Disease Prevention and Control, & European Monitoring Centre for Drugs and Drug Addiction. (2011). Prevention and control of infectious diseases among people who inject drugs. Stockholm: European Centre for Disease Prevention and Control (ECDC).
Keywords: prevention; prevention program; prevention directed at groups; illicit drug; infection; HIV infection; hepatitis B; hepatitis C; tuberculosis; hepatitis A; disease transmission factor; Europe; European Union
|
|
|
|
various. (2012). Guidelines for the evaluation of drug prevention : a manual for programme planners and evaluators (European Monitoring Centre for Drugs and Drug Addiction, Ed.) (2nd ed.). Manuals, 8. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Prevention is a key consideration when discussing substance use and related problems. Drug prevention is any activity that delays or reduces the use of substances. Preventing substance use potentially makes other interventions, especially targeting treatment and harm reduction, unnecessary. Evaluation of the various interventions is essential to develop and improve existing approaches and to work towards creating a best practice in drug prevention. The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate prevention interventions in Europe. These guidelines aimed to facilitate and encourage project leaders to evaluate their own interventions and to design them accordingly. This second edition is an updated version of the original EMCDDA guidelines, which contains new methods, concepts and examples of currently available drug prevention interventions and which provides a framework for carrying out an evaluation. The content has also been updated with developments in online EMCDDA drug prevention and evaluation resources. Since publication of the first edition, prevention professionals who continue to apply these guidelines have contributed to the increased attention given to evaluation and prevention. However, although guidance on drug prevention is available in some Member States, only a minority of interventions in the European Union have an outcome evaluation. Even large, wellfunded projects are still not fully evaluated and the availability of empirical evidence concerning prevention is weak. These guidelines are intended for professionals working in the drug prevention and evaluation field and can provide valuable guidance when planning and evaluating prevention activities. The intention to develop best practice in drug prevention, as expressed in the 2005–8 and 2009–12 EU drugs action plans, and the fact that evaluation is now widely used in Member States’ drug policy, testify to the importance placed on drug prevention and evaluation in the European Union. The aim of this publication is to raise the profile of both drug prevention and evaluation methodologies and to provide prevention practitioners with an up-to-date framework, to enable their interventions and evaluations to reach their full potential.
Keywords: AOD use, abuse, and dependence; research; prevention; prevention outcome; prevention research; prevention directed at groups; recommendations or guidelines; Europe
|
|
|
|
of England, D. of H., Government, T. S., Government, W. A., & Northern Ireland Executive. (2007). Drug misuse and dependence : guidelines on clinical management. London: Department of Health of England; The Scottish Government; Welsh Assembly Government; Northern Ireland Executive;.
Keywords: recommendations or guidelines; health care professionals; physician; social worker; pharmacist; AOD use, abuse, and dependence; AOD dependent; AOD user; intravenous drug user; patient; old age; elderly; adolescent; pregnancy; parent; AOD effects and AODR problems; infection; mental health; AODR mortality; harm reduction; intervention (persuasion to treatment); treatment and maintenance; inpatient care; hospital; drug therapy; opioids in any form; methadone maintenance; buprenorphine; naltrexone; benzodiazepines; licit drug; alcohol; tobacco in any form; law enforcement; criminal penalty; relapse prevention; AOD use and driving; international area; United Kingdom; drug substitution therapy
|
|
|
|
Standing Conference on Drug Abuse. (1997). Drug-related early intervention : developing services for young people and families. London: Standing Conference on Drug Abuse (SCODA).
Keywords: treatment and maintenance; outpatient care; AOD misuse; early identification; early intervention (young children); education; health; social services; adolescent
|
|
|
|
Working Group AIDS and Drugs. (1990). Rock the rat : Rick the pricker. Amsterdam: Author.
|
|
|
|
Community Drug Project. (1989). Safer drug use : the user's guide. London: The Community Drug Project.
|
|
|
|
Harm Reduction Coalition. (1990). Harm Reduction Coalition : working together towards individual and community health. Oakland; New York: Harm Reduction Coalition (HRC).
|
|
|
|
Swiss Federal Office of Public Health. (1999). Prevention and health promotion for young people : objectives : strategies : programs and projects. Berne: Swiss Federal Offfice of Public Health (FOPH), Addiction and AIDS Department, Drug Intervention Section.
|
|
|
|
National Institutes of Drug Abuse. (2003). Preventing drug use among children and adolescents : a research-based guide for parents, educators , and community leaders. Bethesda: U.S. Department of Health and Human Services, National Institutes of Health, National Institutes of Drug Abuse (NIDA).
Keywords: prevention; target group; child; adolescent; AOD use, abuse, and dependence; research; prevention directed at groups; prevention program; community-based prevention; community involvement
|
|
|
|
Department of Health. (2001). Tackling drugs with vulnerable young people : examples from health action zones. London: Author.
Keywords: prevention; adolescent; youth AOD education; AOD misuse; target group; prevention directed at groups; peer prevention
|
|
